Detectrons Turn Fleeting RNA Signals into Lasting DNA Barcodes Inside Living Cells

Every living cell is awash in RNA, a class of molecules that is produced and destroyed at a relentless pace. Because RNA is so transient, catching a specific transcript in the act of being expressed has long required researchers to freeze, lyse, or otherwise destroy the very system they hope to observe. Now a team at the Gladstone Institute of Data Science and Biotechnology and the University of California, San Francisco has unveiled a device that sidesteps this limitation entirely. Writing in Nature Biotechnology, Jihoon Han and Seth L. Shipman describe Detectrons, modular biosensors that listen for a chosen RNA sequence inside a living cell and, upon finding it, write a permanent DNA record of the encounter. The work transforms a fleeting molecular whisper into a durable archival entry that can be read out later by standard DNA sequencing, opening the door to high-throughput studies of RNA-dependent processes that were previously impractical to capture.

The core of the Detectron design marries two molecular technologies that synthetic biologists have refined over the past decade. The first is the toehold switch, a de novo-designed RNA regulator first reported by Green and colleagues in 2014. A toehold switch is a carefully folded strand of RNA that hides a protein-coding or functional sequence behind a hairpin structure. When a complementary trigger RNA binds to an exposed single-stranded ‘toehold’ region, the hairpin opens and the previously sequestered sequence becomes active. Toehold switches are prized because they can be designed almost arbitrarily, letting researchers program sensors for nearly any RNA sequence of interest. Their weakness, however, is that their outputs are typically proteins or RNA molecules that are themselves transient, difficult to multiplex, and poorly suited to sequencing-based readouts.

That is where the second technology enters. Retrons are bacterial genetic elements that naturally produce large amounts of single-stranded DNA inside living cells. A retron consists of a reverse transcriptase enzyme together with a noncoding RNA scaffold, traditionally divided into the msr and msd regions, that the enzyme partially copies into DNA. The result is a covalently linked RNA-DNA hybrid molecule, a peculiar product first characterized in the 1980s and later recognized as part of bacterial anti-phage defense systems. Recent years have seen retrons repurposed as tools for genome editing and DNA recording, and the Shipman laboratory has been at the forefront of that effort. Detectrons fuse the two systems: the toehold switch controls when the retron’s reverse transcriptase activity produces its DNA product, and the sequence of that DNA product serves as a barcode unique to the RNA that triggered it.

In practice, a Detectron is a single engineered RNA molecule. In its default state, the switch region folds into a hairpin that blocks productive priming of reverse transcription. When the target RNA appears and hybridizes to the toehold, the structure rearranges, the retron reverse transcriptase gains access to its template, and a short single-stranded DNA barcode is synthesized. Cells that never encounter the target produce little or no barcode; cells that do encounter it accumulate a measurable DNA record. Because the barcode is DNA, it is stable, it survives conditions that would destroy RNA, and it can be pooled, amplified, and sequenced alongside thousands of other samples. This converts what was once a per-sample fluorescence measurement into a massively parallel counting problem, one that modern sequencing platforms are exceptionally good at solving.

Getting the architecture to work well was not trivial, and much of the new paper is devoted to systematic optimization. The authors constructed a large synthetic library of toehold-retron variants, systematically varying structural parameters such as the lengths of the two stems in the hairpin, the loop that connects them, the bulges that interrupt base pairing, and the distance between the stem and the priming guanine where reverse transcription begins. By measuring barcode production for each variant in both the presence and absence of trigger RNA, they generated a quantitative map of how each design choice affects the on/off ratio, the critical figure of merit that determines how cleanly a sensor distinguishes true signal from background.

Machine learning then extracted design principles from that map. Using XGBoost, a scalable tree-boosting algorithm, the team trained regression models on the variant library and evaluated them with cross-validated metrics including the coefficient of determination, root mean squared error, and Pearson correlation. SHAP analysis, a technique that attributes model predictions to individual features, revealed which structural parameters mattered most. The findings were sometimes counterintuitive: shortening the loop below roughly seven nucleotides sharply degraded both signal strength and on/off ratios, while specific combinations of stem lengths and hairpin folding free energy proved far more predictive of performance than any single parameter alone. Armed with these rules, the researchers built Detectron-V2, a redesigned second-generation device that achieved substantially enhanced on/off ratios and high specificity across a panel of phage transcripts.

To demonstrate the platform’s real-world utility, Han and Shipman turned to bacteriophages, the viruses that infect bacteria. Detectrons were programmed to recognize transcripts from specific phage genes, including the major capsid gene gp23 of phage T4 and sequences from phage T7. When a bacterial cell carrying the appropriate Detectron was infected by the matching phage, the viral RNA triggered barcode synthesis; unrelated phages did not. The team even showed that the response was dose-dependent, with barcode enrichment scaling with the multiplicity of infection, meaning the devices do not merely register that an infection occurred but carry quantitative information about how intense it was. Target-site selection within a viral transcript also mattered, with sites predicted to be more locally accessible by RNA folding algorithms yielding better sensor performance.

The most striking demonstration came in pooled cultures. The researchers mixed together bacterial strains, each carrying a Detectron tuned to a different phage, and infected the pooled population. After sequencing the barcode pool, they could determine which phages had infected which strains within a single pot, without any physical separation of the samples. They extended this to ratiometric susceptibility profiling, in which the relative abundance of barcodes reports quantitatively on how susceptible different host strains are to different phages. For the phage-therapy field, where matching the right phage to the right bacterial infection is the central clinical challenge and current methods require growing each phage-host pair separately, a pooled sequencing-based assay of this kind could dramatically accelerate screening.

Beyond virology, Detectrons join a growing family of molecular recording technologies that include CRISPR-based recorders and recombinase state machines, but they occupy a distinctive niche. Where CRISPR recorders typically write into the genome through DNA cleavage events, Detectrons produce their records through reverse transcription of an engineered RNA template, a process that does not require the recorder to target the cell’s own DNA. That makes the approach potentially safer and more modular, and the authors note that the framework enables alternative modes of transcript-based sensing with applications including viral infection detection more broadly. The ability to record transcriptional events in complex bacterial communities, such as microbiomes, suggests uses in environmental monitoring and diagnostics where cells must be observed in place rather than disrupted.

The work also carries the familiar caveats of early synthetic biology. The demonstrations were performed in engineered bacterial strains with inducible promoters and defined phage infections, and porting the technology to other organisms, to natural microbial communities, or to mammalian cells will require re-optimization of the switch architecture for each new context. Han and Shipman have filed a provisional patent application on the technology, signaling commercial interest, and the complete variant libraries, sequences, code, and statistical data have been released to support replication and extension by other groups. Still, the conceptual advance is clear: a programmable RNA sensor whose output is not a fading fluorescent glow but a stable, sequenceable, multiplexable DNA barcode. As the design rules mature, devices of this kind could turn living cells into their own record-keepers, quietly logging which genes spoke and when, for anyone with a sequencer to read the archive.

Subject of Research: Synthetic RNA biosensors that record transcript detection as DNA barcodes via retron reverse transcription

Article Title: Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes

Article References: Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes. (n.d.). https://doi.org/10.1038/s41587-026-03334-7

Image Credits: AI Generated

DOI: 10.1038/s41587-026-03334-7

Keywords: Detectrons, toehold switches, retrons, reverse transcriptase, DNA barcodes, RNA sensing, synthetic biology, bacteriophages, phage therapy, machine learning, molecular recording, Nature Biotechnology